Angiotensin converting enzyme inhibitors have greatly improved the treatment of patients with chronic heart failure but they are not effective in all patients, and their use may be limited by side effects. There is, therefore, a need to investigate new drugs and to compare their efficacy with angiot
A Comparative Study of the First Dose Hypotensive Effects of Captopril and Perindopril in Patients with Heart Failure
โ Scribed by Portuguese Community Hospital Study Group on Heart Failure,
- Book ID
- 110323893
- Publisher
- Springer US
- Year
- 2001
- Tongue
- English
- Weight
- 155 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0920-3206
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We have studied the acute and chronic effects of an ACE inhibitor (captopril) on platelet function and the renin-angiotensin system in patients with congestive heart failure. Plasma concentrations of angiotensin II fell significantly after a single dose of captopril (25 mg) and during long-term trea
Objective: The pharmacokinetics and pharmacodynamics of buffered sublingual captopril were assessed in patients with congestive heart failure (CHF). Methods: The study was carried out in a randomised single-blind cross-over fashion (n = 6, 4 males and 2 females) and involved two study days, at least
The acute central haemodynamic and neuroendocrine effects of intravenous flosequinan were studied in a group of 10 patients with severe heart failure. Flosequinan improved cardiac output by a maximum of 1.59 l.min-1, it reduced pulmonary capillary wedge pressure by 11.9 mm Hg and it also caused a re